ACTIVE

OFFIPHARMA

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

-5,0 k €

-126.0% YoY

Gross margin

124,7 k €

-21.1% YoY

Equity

261,1 k €

-1.9% YoY

Workforce

1,5 ETP

+7.1% YoY

What does OFFIPHARMA do?

OFFIPHARMA is a Private limited company incorporated in 2004. Its registered office is in Froidchapelle. It employs on average 1,5 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0864.276.532

Incorporation

24/03/2004

Legal form

Private limited company

Registered office

Rue du Gouty(FRO) 22
6440 Froidchapelle · WallonieSee on map

Contributed capital

18 600,00 €

Latest accounts

31/12/2025

Average workforce

1,5 ETP

Joint committees (2)

Signals

Solid equityLow riskGood liquidityPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	124,7 k €	-21.1%	158,0 k €	+5.2%	150,2 k €	-26.2%	203,4 k €	+16.8%	174,2 k €	+4.0%	167,4 k €	+8.1%	154,9 k €	+38.3%	112,0 k €	-2.5%	114,9 k €	-6.4%	122,8 k €	+1.9%	120,5 k €	-13.4%	139,2 k €	+2.6%	135,7 k €	+6.0%	128,0 k €	-7.8%	138,8 k €	+5.1%	132,0 k €	-10.5%	147,5 k €	+8.9%	135,5 k €	-6.4%	144,8 k €	-6.7%	155,1 k €
EBITDA	5,0 k €	-87.8%	41,2 k €	-31.7%	60,3 k €	-38.2%	97,5 k €	-0.2%	97,7 k €	+7.6%	90,8 k €	+20.1%	75,6 k €	+173%	27,7 k €	-18.5%	34,0 k €	-29.6%	48,3 k €	+21.3%	39,8 k €	-32.3%	58,9 k €	+0.2%	58,8 k €	+50.4%	39,1 k €	-15.8%	46,4 k €	+12.8%	41,1 k €	-26.8%	56,2 k €	+19.6%	47,0 k €	-24.1%	61,9 k €	-12.1%	70,5 k €
Operating result	442,1 €	-98.7%	33,2 k €	-36.3%	52,1 k €	-41.5%	89,1 k €	+23.3%	72,3 k €	+11.2%	65,0 k €	+43.7%	45,3 k €	+179%	16,2 k €	-37.7%	26,0 k €	-38.8%	42,5 k €	+22.4%	34,7 k €	-26.3%	47,1 k €	+72.4%	27,3 k €	+261%	7,6 k €	-24.6%	10,0 k €	+127%	4,4 k €	-75.9%	18,3 k €	+139%	7,7 k €	-65.3%	22,1 k €	-31.9%	32,4 k €
Net result	-5,0 k €	-126%	19,2 k €	-42.9%	33,6 k €	-46.3%	62,7 k €	+23.0%	51,0 k €	+12.3%	45,4 k €	+61.1%	28,2 k €	+199%	9,4 k €	-34.5%	14,4 k €	-36.4%	22,6 k €	+7.9%	21,0 k €	-34.5%	32,0 k €	+118%	14,7 k €	+792%	1,6 k €	+31.1%	1,3 k €	+144%	-2,9 k €	-137%	7,7 k €	+67.1%	4,6 k €	+91.8%	2,4 k €	-85.4%	16,5 k €
Balance sheet
Equity	261,1 k €	-1.9%	266,1 k €	+7.8%	246,9 k €	+10.9%	222,7 k €	+28.0%	174,0 k €	-24.9%	231,7 k €	-0.7%	233,3 k €	+13.7%	205,1 k €	+4.8%	195,7 k €	+7.9%	181,3 k €	+14.2%	158,7 k €	+15.2%	137,8 k €	+308%	33,8 k €	-67.5%	103,8 k €	-0.7%	104,6 k €	-1.1%	105,7 k €	-2.6%	108,6 k €	+7.6%	100,9 k €	+4.8%	96,2 k €	+2.6%	93,8 k €
Total assets	399,8 k €	+1.6%	393,5 k €	+1.8%	386,7 k €	+7.8%	358,6 k €	+11.3%	322,2 k €	-10.6%	360,4 k €	-17.8%	438,7 k €	+12.5%	390,1 k €	-2.2%	398,8 k €	+7.1%	372,5 k €	+4.7%	355,7 k €	+6.2%	335,0 k €	+10.1%	304,3 k €	-16.4%	364,0 k €	-10.5%	406,7 k €	-6.8%	436,2 k €	-9.7%	483,1 k €	-9.3%	532,9 k €	-3.2%	550,6 k €	-1.8%	560,5 k €
Cash	184,3 k €	-2.4%	188,8 k €	+1.8%	185,6 k €	+10.8%	167,4 k €	+11.1%	150,6 k €	-22.5%	194,4 k €	-23.8%	255,1 k €	+12.9%	226,0 k €	-3.6%	234,5 k €	+29.8%	180,7 k €	+15.9%	155,9 k €	+13.9%	136,8 k €	+30.7%	104,7 k €	+65.6%	63,2 k €	-13.4%	73,0 k €	+2.1%	71,6 k €	-28.4%	99,9 k €	-17.5%	121,1 k €	-0.8%	122,1 k €	-16.8%	146,8 k €
Debts	138,6 k €	+8.8%	127,4 k €	-6.2%	135,7 k €	-0.1%	135,9 k €	-8.3%	148,2 k €	+15.1%	128,7 k €	-37.3%	205,3 k €	+11.0%	184,9 k €	-8.9%	203,1 k €	+6.2%	191,2 k €	-2.9%	197,0 k €	-0.1%	197,2 k €	-26.9%	269,8 k €	+4.1%	259,1 k €	-13.9%	301,1 k €	-5.5%	318,7 k €	-12.2%	362,9 k €	-13.5%	419,5 k €	-5.2%	442,3 k €	-2.7%	454,5 k €
Other
Workforce	1,5 ETP	+7.1%	1,4 ETP	-6.7%	1,5 ETP	+7.1%	1,4 ETP	+7.7%	1,3 ETP	0.0%	1,3 ETP	0.0%	1,3 ETP	-13.3%	1,5 ETP	0.0%	1,5 ETP	+7.1%	1,4 ETP	-12.5%	1,6 ETP	+14.3%	1,4 ETP	-6.7%	1,5 ETP	+15.4%	1,3 ETP	-53.6%	2,8 ETP	+55.6%	1,8 ETP	-14.3%	2,1 ETP	-25.0%	2,8 ETP	+40.0%	2,0 ETP	0.0%	2,0 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 4 ended

Active mandates

Brigitte RASKINET

Director · since 13 avril 2021

Active

Ended mandates

Brigitte RASKINET

Mandate · since 01 avril 2004

Ended

Brigitte RASKINET

Manager · since 01 avril 2004 · until 13 avril 2021

Ended

Brigitte RASKINET

Manager · since 01 avril 2004

Ended

BRIGITTE RASKINET

Manager

Ended

At this address

Other companies at this address

Company	CBE no.
Immobilière PHARMIMMO● Active	0444.090.447

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	31/08/2026	18/07/2025	19/07/2024	20/07/2023	07/07/2022	12/07/2021
General meeting	31/08/2026	24/05/2025	25/05/2024	27/05/2023	28/05/2022	26/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	31/08/2026	31/08/2026	French	PDF
Abridged model	31/12/2024	24/05/2025	18/07/2025	French	PDF
Abridged model	31/12/2023	25/05/2024	19/07/2024	French	PDF
Abridged model	31/12/2022	27/05/2023	20/07/2023	French	PDF
Abridged model	31/12/2021	28/05/2022	07/07/2022	French	PDF
Abridged model	31/12/2020	26/06/2021	12/07/2021	French	PDF
Abridged model	31/12/2019	27/06/2020	14/08/2020	French	PDF
Abridged model	31/12/2018	22/06/2019	26/08/2019	French	PDF
Abridged model	31/12/2017	23/06/2018	24/08/2018	French	PDF
Abridged model	31/12/2016	24/06/2017	22/08/2017	French	PDF
Abridged model	31/12/2015	25/06/2016	08/08/2016	French	PDF
Abridged model	31/12/2014	27/06/2015	20/08/2015	French	PDF
Abridged model	31/12/2013	28/06/2014	29/08/2014	French	PDF
Abridged model	31/12/2012	26/05/2013	01/08/2013	French	PDF
Abridged model	31/12/2011	26/05/2012	19/06/2012	French	PDF
Abridged model	31/12/2010	28/05/2011	25/07/2011	French	PDF
Abridged model	31/12/2009	29/05/2010	25/06/2010	French	PDF
Abridged model	31/12/2008	27/06/2009	22/07/2009	French	PDF
Abridged model	31/12/2007	14/06/2008	22/07/2008	French	PDF
Abridged model	31/12/2006	09/06/2007	06/07/2007	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 4 ended

Active mandates

Brigitte RASKINET

Director · since 13 avril 2021

Active

Ended mandates

Brigitte RASKINET

Mandate · since 01 avril 2004

Ended

Brigitte RASKINET

Manager · since 01 avril 2004 · until 13 avril 2021

Ended

Brigitte RASKINET

Manager · since 01 avril 2004

Ended

BRIGITTE RASKINET

Manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates15/04/2021
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
PDF
Capital / shares10/02/2014
CAPITAL, ACTIONS
PDF
Capital / shares17/06/2004
DIVERS - CAPITAL, ACTIONS
PDF
Other09/04/2004
RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025-5,0 k €↓
2024
Annual accounts 202419,2 k €↓
2023
Annual accounts 202333,6 k €↓
2022
Annual accounts 202262,7 k €↑
2021
Annual accounts 202151,0 k €↑
2020
Annual accounts 202045,4 k €↑
2019
Annual accounts 201928,2 k €↑
2018
Annual accounts 20189,4 k €↓
2017
Annual accounts 201714,4 k €↓
2016
Annual accounts 201622,6 k €↑
2015
Annual accounts 201521,0 k €↓
2014
Annual accounts 201432,0 k €↑
2013
Annual accounts 201314,7 k €↑
2012
Annual accounts 20121,6 k €↑
2011
Annual accounts 20111,3 k €↑
2010
Annual accounts 2010-2,9 k €↓
2009
Annual accounts 20097,7 k €↑
2008
Annual accounts 20084,6 k €↑
2007
Annual accounts 20072,4 k €↓
2006
Annual accounts 200616,5 k €
24/03/2004
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

OFFIPHARMA

Overview

What does OFFIPHARMA do?

Trend over 20 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline